BeyondSpring Inc. Accumulated Other Comprehensive Income
BeyondSpring Inc. (BYSI) had Accumulated Other Comprehensive Income of $55.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $55.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $360.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $602.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $913.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $55.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $360.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $602.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $913.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.02M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.24M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.34M 10-K · filed 2026-03-25 |
| 2024-06-30 | $1.26M 6-K · filed 2024-08-29 |
| 2023-12-31 | $894.00K 10-K · filed 2025-03-27 |
| 2023-06-30 | $1.22M 6-K · filed 2024-02-02 |
| 2022-12-31 | $436.00K 6-K · filed 2024-02-02 |
| 2022-06-30 | $117.00K 6-K · filed 2023-02-28 |
| 2021-12-31 | -$523.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | -$398.00K 6-K · filed 2021-12-30 |
| 2021-06-30 | -$366.00K 6-K · filed 2021-09-10 |
| 2021-03-31 | -$247.00K 6-K · filed 2021-06-16 |
| 2020-12-31 | -$297.00K 20-F · filed 2023-04-18 |
| 2020-09-30 | -$47.00K 6-K · filed 2020-11-17 |
| 2020-06-30 | $197.00K 6-K · filed 2020-09-03 |
| 2020-03-31 | $197.00K 6-K · filed 2020-06-11 |
| 2019-12-31 | $140.00K 20-F · filed 2023-04-18 |
| 2019-09-30 | $225.00K 6-K · filed 2019-12-18 |
| 2019-06-30 | $76.00K 6-K · filed 2019-09-18 |
| 2019-03-31 | -$111.00K 6-K · filed 2019-07-10 |
| 2018-12-31 | $42.00K 20-F · filed 2020-04-30 |
| 2018-06-30 | -$100.00K 6-K · filed 2018-10-23 |
| 2018-03-31 | -$278.00K 6-K · filed 2018-06-21 |
| 2017-12-31 | -$182.00K 20-F · filed 2019-04-30 |
| 2017-09-30 | -$163.00K 6-K · filed 2017-11-09 |
| 2017-06-30 | -$94.00K 6-K · filed 2017-08-21 |
| 2017-03-31 | -$96.00K 6-K · filed 2017-05-22 |
| 2016-12-31 | -$91.00K 20-F · filed 2018-04-03 |
| 2015-12-31 | -$53.00K 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |